Skip to main content

Table 3 The main differences in the defined assessment measures with TNF-I at 6 months

From: Predictors of European League Against Rheumatism (EULAR) good response, DAS-28 remission and sustained responses to TNF-inhibitors in rheumatoid arthritis: a prospective study in refractory disease

Measures Responders Non responders Significance
P-value
ESR 23.56 ± 13.58 28 ± 16.87 <0.05*
CRP 6.66 ± 4.81 14.82 ± 17.90 <0.05*
Hb% 12.61 ± 1.09 12.01 ± 0.87 >0.05
DAS-28 2.80 ± 1.15 4.35 ± 1.24 <0.05*
RF at 6 months 118.84 ± 127.55 66.60 ± 74.16 <0.05*
  1. *P value< 0.05 is considered statistically significant.